Remdesivir Active Not Recruiting Phase 3 Trials for Novel Coronavirus Infectious Disease (COVID-19) Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT04401579Adaptive COVID-19 Treatment Trial 2 (ACTT-2)